000048425 000__ 01484cam\a22003975i\4500
000048425 001__ 48425
000048425 003__ SzGeWIPO
000048425 005__ 20240708150405.0
000048425 006__ m\\\\eo\\d\\\\\\\\
000048425 007__ cr bn |||m|||a
000048425 008__ 230714s2023    nyu|||||o|||||000|0 eng|d
000048425 035__ $$a(OCoLC)1393694890
000048425 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO
000048425 041__ $$aeng
000048425 24500 $$aEuropean Union: Bayer Intellectual Property.
000048425 264_1 $$a[New York, NY] :$$bThomson Reuters,$$c2023
000048425 300__ $$a1 online resource
000048425 336__ $$atext$$2rdacontent
000048425 337__ $$acomputer$$2rdamedia
000048425 338__ $$aonline resource$$bcr$$2rdacarrier
000048425 4901_ $$aInternational Review of Intellectual Property Law & Competition Law ;$$vVolume 54, Issue 3
000048425 542__ $$fhttps://1.next.westlaw.com/Copyright
000048425 588__ $$aCrossref
000048425 590__ $$aPublished online: 2023
000048425 650_0 $$aIntellectual property.$$zEuropean Union.
000048425 650_0 $$aInternational trade.
000048425 650_0 $$aTrademarks.
000048425 650_0 $$aTrademark infringement.
000048425 650_0 $$aPharmaceuticals.
000048425 650_0 $$aIntellectual property.
000048425 7731_ $$tInternational Review of Intellectual Property Law & Competition Law
000048425 7731_ $$wIIC
000048425 830_0 $$aInternational Review of Intellectual Property Law & Competition Law ;$$vVolume 54, Issue 3.
000048425 85641 $$uhttps://www.westlaw.com/Document/I86870700DD7D11ED999BD7C0C2185523/View/FullText.html?transitionType=Default&contextData=(sc.Default)&VR=3.0&RS=cblt1.0&sp=wlnintell-000$$yonline version
000048425 904__ $$aJournal article
000048425 980__ $$aIIC